The creative collective disrupting healthcare communications for the better. Healthcare is one of the fastest changing industries on the planet. With Disruption® as our philosophy, TBWAWorldHealth ...
Tagrisso (osimertinib) has been approved by the US Food and Drug Administration (FDA) to treat a new subset of lung cancer ...
Sanofi’s Sarclisa (isatuximab) has been approved by the US Food and Drug Administration (FDA) as part of a first-line ...
Eli Lilly and Almirall have announced positive long-term results for their targeted IL-13 inhibitor Ebglyss ...
Traditional information gathering across the pharmaceutical industry, collected directly from healthcare professionals (HCPs) ...
From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a ...
AMICULUM is delighted to have contributed to the MediaplanetUK Rare Diseases Campaign 2024, published in The Guardian on ...
The US Food and Drug Administration (FDA) has approved Zevra Therapeutics’ Miplyffa (arimoclomol) to treat Niemann-Pick ...
Wherever you sit in the partnership triangle, does it sound familiar? Many initiatives have tried to address this partnership ...
Less attention has been given to the impact AI can have at the later stages of drug development and on patient access. This ...
Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to explore ...
Picture this: a medicine targeting a particular disease is developed over 12-15 years from initial candidate selection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback